Cardiovascular Reprogramming and Regeneration Conference 2025
Join leading experts, researchers, and clinicians at the CRR 2025 Conference in Baltimore, where we will explore the latest advances in cardiac reprogramming, regeneration, and bioengineering. This one-day event features distinguished speakers, interactive sessions, and networking opportunities, fostering collaboration and innovation in the field of cardiovascular science.
July 21, 2025
Baltimore Marriott Waterfront
Waterview Room, 1st Floor
700 Aliceanna Street
Baltimore, MD 21202
Featured Speakers
Joseph C. Wu, MD, PhD
Stanford University
Li Qian, PhD
University of North Carolina
Hee Cheol Cho, PhD
Johns Hopkins University
Kyoung-Han Kim, PhD
University of Ottawa
Daniel J. Garry, MD, PhD
University of Minnesota
Changwon Park, PhD
LSU Health Shreveport
Jinhu Wang, PhD
Emory University
Young-sup Yoon, MD, PhD
Emory University/Georgia Tech/Yonsei University
Da-Zhi Wang, PhD
University of South Florida
Hun-Jun Park, MD, PhD
Catholic University, Korea
Sung-Jin Park, PhD
Emory University/Georgia Tech
Michael A. Laflamme, MD, PhD
University of Toronto, Canada
Jay Zhang, MD, PhD
University of Alabama Birmingham
Hyuk Jin Cha, PhD
Seoul National University, Korea
Chul-Hwan Lee, PhD
Seoul National University, Korea
Jaecheol Lee, PhD
Sungkyunkwan University, Korea
Session Chairs
Youngkeun Ahn, MD, PhD
Chonnam National University, Korea
Sang-Ho Lee, PhD
Emory University
Soah Lee, PhD
Sungkyunkwan University, Korea
Yong Sook Kim, PhD
Chonnam National University, Korea
Conference Agenda
Program Details
| Session I | Cardiomyocyte reprogramming & regeneration |
| 08:30-08:55 | Joseph C. Wu, MD, PhD Stem Cells & Genomics for Clinical Trial in Dish |
| 08:55-09:20 | Li Qian, PhD Turning Fibroblasts into Cardiomyocytes: The Journey and the Road Ahead |
| 09:20-09:45 | Hee Cheol Cho, PhD Advancing Cardiac Pacing by Gene Therapy |
| 09:45-10:10 | Kyoung-Han Kim, PhD Understanding and Establishing Heterogeneity in the Cardiac Conduction System |
| Session II | Vascular reprogramming & regeneration |
| 10:30-10:55 | Daniel J. Garry, MD, PhD Mechanisms that Govern ETV2 Mediated Reprogramming and Angiogenesis |
| 10:55-11:20 | Changwon Park, PhD The Role of Autism Spectrum Disorder Risk Gene, Shank3, in Blood Brain Barrier |
| 11:20-11:45 | Jinhu Wang, PhD Characterizing Epicardial Subpopulation Function during Adult Zebrafish Heart Regeneration |
| 11:45-12:10 | Young-sup Yoon, MD, PhD Vascular Regeneration with Stem Cells, Reprogrammed Cells and Engineering Technologies |
| Session III | Cardiac biology and organoids |
| 13:30-13:55 | Da-Zhi Wang, PhD Role of the Pcbp1-Aars2 Axis in Ventricular non-Compaction and Congenital Heart Defects |
| 13:55-14:20 | Michael A. Laflamme, MD, PhD Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes in vitro and in vivo |
| 14:20-14:45 | Hun-Jun Park, MD, PhD Therapeutic Potential of 3D Multi-Cellular Cardiac Spheroids Derived from Human Pluripotent Stem Cells for Cardiac Regeneration |
| 14:45-15:10 | Sung-Jin Park, PhD Advanced cardiac tissue engineering |
| Session IV | Bioengineering |
| 15:30-15:55 | Jay Zhang, MD, PhD Remuscularization of Injured Ventricle in Large Mammals |
| 15:55-16:20 | Chul-Hwan Lee, PhD EZH1-Mediated Epigenetic Shaping of Chromatin Architecture Governs Cardiomyocyte Maturation |
| 16:20-16:45 | Jaecheol Lee, PhD Human iPSC-Based Disease Models: From Mechanistic Insights to Predictive Platforms |
| 16:45-17:10 | Hyuk Jin Cha, PhD Characterization of Genetically Aberrant Human Pluripotent Stem Cells for Detection and Prevention |